109 related articles for article (PubMed ID: 9021436)
1. Urinary 6 beta-hydroxycortisol and D-glucaric acid excretion rates are not affected by lansoprazole treatment.
Rost KL; Mansmann U; Roots I
Int J Clin Pharmacol Ther; 1997 Jan; 35(1):14-8. PubMed ID: 9021436
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of Saint John's Wort (hypericum perforatum) on the urinary excretion of D-glucaric acid and 6beta-hydroxycortisol in healthy volunteers.
Bauer S; Störmer E; Kerb R; Johne A; Brockmöller J; Roots I
Eur J Clin Pharmacol; 2002 Dec; 58(9):581-5. PubMed ID: 12483450
[TBL] [Abstract][Full Text] [Related]
3. Lansoprazole does not affect the bioavailability of oral contraceptives.
Fuchs W; Sennewald R; Klotz U
Br J Clin Pharmacol; 1994 Oct; 38(4):376-80. PubMed ID: 7833230
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
Ushiama H; Echizen H; Nachi S; Ohnishi A
Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002
[TBL] [Abstract][Full Text] [Related]
5. Specific and dose-dependent enzyme induction by omeprazole in human beings.
Rost KL; Brösicke H; Heinemeyer G; Roots I
Hepatology; 1994 Nov; 20(5):1204-12. PubMed ID: 7927253
[TBL] [Abstract][Full Text] [Related]
6. D-glucaric acid excretion in critical care patients--comparison with 6 beta-hydroxycortisol excretion and serum gamma-glutamyltranspeptidase activity and relation to multiple drug therapy.
Heinemeyer G; Roots I; Lestau P; Klaiber HR; Dennhardt R
Br J Clin Pharmacol; 1986 Jan; 21(1):9-18. PubMed ID: 2868749
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of 6 beta-hydroxycortisol as an in vivo marker for CYP3A induction: applications and recommendations.
Kovacs SJ; Martin DE; Everitt DE; Patterson SD; Jorkasky DK
Clin Pharmacol Ther; 1998 Jun; 63(6):617-22. PubMed ID: 9663175
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, placebo-controlled study on the effect of vigabatrin on in vivo parameters of hepatic microsomal enzyme induction and on the kinetics of steroid oral contraceptives in healthy female volunteers.
Bartoli A; Gatti G; Cipolla G; Barzaghi N; Veliz G; Fattore C; Mumford J; Perucca E
Epilepsia; 1997 Jun; 38(6):702-7. PubMed ID: 9186253
[TBL] [Abstract][Full Text] [Related]
9. Effect of troglitazone on urinary excretion of 6beta-hydroxycortisol.
Koup JR; Anderson GD; Loi CM
J Clin Pharmacol; 1998 Sep; 38(9):815-8. PubMed ID: 9753209
[TBL] [Abstract][Full Text] [Related]
10. [Variation in the urinary excretion of 6-beta-hydroxycortisol in humans after administration of the new isoquinoline derivative, PK-11195 (52028 RP)].
Freche JP; Decolin D; Siest JP; Batt AM; Panis-Rouzier R; Siest G
Therapie; 1989; 44(5):327-30. PubMed ID: 2573163
[TBL] [Abstract][Full Text] [Related]
11. Relationship between changes in drug score, D-glucaric acid excretion, and gamma-glutamyltransferase and beta-glucuronidase serum activities during anticonvulsant treatment.
Hermida J; Fernández MP; Tutor JC
Clin Lab; 2002; 48(7-8):415-9. PubMed ID: 12146576
[TBL] [Abstract][Full Text] [Related]
12. Omeprazole and lansoprazole are not inducers of cytochrome P4501A2 under conventional therapeutic conditions.
Rizzo N; Padoin C; Palombo S; Scherrmann JM; Girre C
Eur J Clin Pharmacol; 1996; 49(6):491-5. PubMed ID: 8706775
[TBL] [Abstract][Full Text] [Related]
13. Phenobarbitone-induced urinary excretions of D-glucaric acid and 6beta-hydroxycortisol in man.
Latham AN; Turner P; Franklin C; Maclay W
Can J Physiol Pharmacol; 1976 Oct; 54(5):778-82. PubMed ID: 991005
[TBL] [Abstract][Full Text] [Related]
14. A simple non-invasive procedure for the investigation of cytochrome P-450 IIIA dependent enzymes in humans.
Bienvenu T; Rey E; Pons G; d'Athis P; Olive G
Int J Clin Pharmacol Ther Toxicol; 1991 Nov; 29(11):441-5. PubMed ID: 1800391
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms.
Ko JW; Sukhova N; Thacker D; Chen P; Flockhart DA
Drug Metab Dispos; 1997 Jul; 25(7):853-62. PubMed ID: 9224780
[TBL] [Abstract][Full Text] [Related]
16. Concentrations of D-glucaric acid in human urine after repeated administration of pyrithioxine.
Freundt KJ; Liedy G; Voigt HO
Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):639-42. PubMed ID: 6526537
[TBL] [Abstract][Full Text] [Related]
17. Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies.
Howden CW; Henning JM; Huang B; Lukasik N; Freston JW
Am J Gastroenterol; 2001 Jun; 96(6):1704-10. PubMed ID: 11419818
[TBL] [Abstract][Full Text] [Related]
18. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
Middeldorp S; Meijers JC; van den Ende AE; van Enk A; Bouma BN; Tans G; Rosing J; Prins MH; Büller HR
Thromb Haemost; 2000 Jul; 84(1):4-8. PubMed ID: 10928461
[TBL] [Abstract][Full Text] [Related]
19. [6 beta-hydroxycortisol: a non-invasive reflection of enzymes of drug metabolism].
Zhiri A; Wellman-Bednawska M; Siest G
Pathol Biol (Paris); 1987 Sep; 35(7):1087-93. PubMed ID: 3313218
[TBL] [Abstract][Full Text] [Related]
20. Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals.
Galteau MM; Shamsa F
Eur J Clin Pharmacol; 2003 Dec; 59(10):713-33. PubMed ID: 14605790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
